For 150 years globally and 35 years in Hungary, Eli Lilly and Company has been driven by a simple belief: meaningful progress happens when scientific innovation, long-term commitment and strong partnerships come together.

Today, Lilly is not only advancing science; it is helping ensure that scientific progress becomes real progress for patients, while strengthening the ecosystem that brings innovation from discovery to impact.

Lilly’s 35-year presence in Hungary is not merely an anniversary milestone. It is proof that long-term commitment creates a lasting impact. Through continuous investment in innovation, clinical research, scientific collaboration and talent development, the company has become a trusted partner in the evolution of the Hungarian healthcare landscape.

Hungary is viewed not only as a market, but as a strategic location where Lilly can contribute to improving patient outcomes, advancing scientific excellence and strengthening the country’s innovation ecosystem.

This commitment is reflected in Lilly’s growing investment in clinical research. By participating in the firm’s global research network, Hungarian patients, healthcare institutions, and experts contribute to scientific advances that extend far beyond national borders.

Clinical research not only supports better healthcare outcomes but also attracts investment, strengthens scientific capabilities, and enhances Hungary’s position within the knowledge economy. This is why healthcare innovation should be seen not only as a health issue, but also as a competitiveness issue, the firm says.

Throughout its history, Lilly has focused on some of the most complex health challenges of each era. Today, it continues to invest in breakthrough science across areas such as cardiometabolic diseases, oncology, immunology and neuroscience, fields that have a profound impact on both public health and economic productivity.

Innovatively Creating the Future

Lilly says it believes that the future of healthcare will be shaped by earlier intervention, better disease management, data-driven decision-making, and stronger collaboration across the healthcare ecosystem. True innovation does not follow the future; it helps create it.

Behind every scientific breakthrough are people who help transform scientific discovery into moments that matter for patients. Lilly’s culture is built on curiosity, integrity, excellence, and continuous learning.

As a global organization, the company invests in talent with the same long-term perspective that it applies to research and innovation, empowering its people to grow, collaborate internationally, and help shape the next generation of healthcare solutions. “Science alone does not change lives; People do,” the firm argues.

As Lilly celebrates 150 years globally and 35 years in Hungary, the focus is not on looking back, but on what comes next: accelerating innovation, strengthening partnerships, investing in people, and helping shape a healthcare system prepared for the challenges of tomorrow.

As the firm says in its 150th year anniversary manifesto, “Our legacy is what we do next.”

This article was first published in the Budapest Business Journal print issue of July 17, 2026.